Research, reports and guidelines
Links to further reading, research and guidelines relevant to the management of hepatitis C.
SIGN 92: Management of hepatitis C – a national clinical guideline
Get the full text of SIGN's guidance and the quick reference guide:
- Download full Guideline text [PDF – 562 Kb]
- Download Quick Reference Guide [PDF – 162 Kb]
The Scottish Medicines Consortium advice on pegylated IFN and ribavirin
The Scottish Medicines Consortium has issued advice on the use of pegylated IFN and ribavirin, for the treatment of children from three years of age, adolescents and adults with chronic hepatitis C. Further details are available from their website: www.scottishmedicines.org.uk
NICE technology appraisal guidance no.106. Peginterferon alfa and ribavirin for the treatment of mild hepatitis C
Online and downloadable guidance, including a quick reference guide and information for patients, from the National Institute of Health and Clinical Excellence.
NICE technology appraisal guidance no.75. Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
Online and downloadable guidance, including a quick reference guide and information for patients, from the National Institute of Health and Clinical Excellence.
